Skip to content
Abierto
Menu

Award notice

Notice of Intent to Sole Source: Canine Oxygen Carrier Manufacturing Restoration and Regulatory Activities

HT942525C0035

Defense Health Agency (Dha), Army Med Res Acq Activity. Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).

View on SAM.govMarkdown

Awarded

Hemoglobin Oxygen Therapeutics LLC

$12,534,579.00 on the award notice, May 22, 2025, contract HT942525C0035

Description

As published on SAM.gov.

This requirement is intended to 1) restore manufacturing operations and processes and 2) obtain regulatory approval of Oxyglobin®, a canine oxygen carrier for use in damage control resuscitation of military working dogs. Anticipated activities may include (but are not limited to) manufacturing process optimization and implementation; manufacturing process validation; and regulatory strategy and development.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Hemoglobin Oxygen Therapeutics LLC
UEI
UJAMF5FC81N9
CAGE
7NSG9
Vendor location
Souderton, PA
Contract
HT942525C0035, definitive contract
Obligated
$9,559,947.80, current value $12,534,579
Actions
6 between May 22, 2025 and March 16, 2026
Competition
Not Competed, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
Canine Oxygen Carrier Manufacturing Restoration and Regulatory Activities
Match
award number HT942525C0035 equals the contract number; same awarding office HT9425 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. May 28, 2025

    Award notice, originally special notice

    Awarded to HEMOGLOBIN OXYGEN THERAPEUTICS LLC Souderton for $12,534,579. SAM.gov, notice c3e9464c192a48abbe7c7dbeb2976057

Points of contact

Also open from this buyer